Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Arcus is an oncology-focused biopharmaceutical company leveraging its deep cross-discipline expertise to discover highly differentiated therapies and develop a broad portfolio of novel combinations addressing significant unmet needs. Arcus’s lead small molecule programs target the adenosine axis, which has been shown to play a significant role in driving immuno-suppression in the tumor micro-environment.

List your booth number for exhibitions, ask us